Literature DB >> 27132691

Defining optimal initial therapy for primary CNS lymphoma.

David Schiff1, Fangxin Hong2, Brian Alexander3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27132691     DOI： 10.1016/S2352-3026(16)30021-7

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN： 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  2 in total

Review 1.  Primary central nervous system lymphoma: essential points in diagnosis and management.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

2.  Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).

Authors:  Hanne Kuitunen; Susanna Tokola; Topi Siniluoto; Matti Isokangas; Eila Sonkajärvi; Seppo Alahuhta; Taina Turpeenniemi-Hujanen; Esa Jantunen; Tapio Nousiainen; Kaija Vasala; Outi Kuittinen
Journal:  J Neurooncol       Date:  2016-10-17       Impact factor: 4.130
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.